Overview
Scott Pierce is a Hematologist in Lexington, Kentucky. Dr. Pierce is highly rated in 55 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Familial Colorectal Cancer, Paget Disease of the Breast, and Pleuropulmonary Blastoma. Dr. Pierce is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3470 Blazer Pkwy Ste 300, Lexington, KY 40509
227 Falcon Dr Ste 103, Mount Sterling, KY 40353
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Health Service
Gregory Monohan is a Hematologist in Lexington, Kentucky. Dr. Monohan is highly rated in 24 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Plasmacytoma, Smoldering Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Kentucky Children's Hospital
Aju Mathew is a Hematologist in Lexington, Kentucky. Dr. Mathew is highly rated in 7 conditions, according to our data. His top areas of expertise are Breast Cancer, Angiosarcoma, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer).
Office
Susan Liddle is a Hematologist in Lexington, Kentucky. Dr. Liddle is highly rated in 17 conditions, according to our data. Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Small Cell Lung Cancer (SCLC).
Frequently Asked Questions about Dr. Scott Pierce
How do I make an appointment with Dr. Scott Pierce?
You can book an appointment with Dr. Scott Pierce by calling their office at 859-215-7402. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Scott Pierce a top-rated expert for Non-Hodgkin Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Scott Pierce is classified as an Distinguished expert for Non-Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Scott Pierce specialize in?
While Dr. Scott Pierce is a Hematology, they have specific expertise in Non-Hodgkin Lymphoma, Familial Colorectal Cancer, and Paget Disease of the Breast. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Scott Pierce participate in research or clinical trials?
Yes. Dr. Scott Pierce has published 1 articles and abstracts on conditions like Non-Hodgkin Lymphoma. You can view a list of Dr. Scott Pierce's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Scott Pierce accept my insurance?
Dr. Scott Pierce accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 859-215-7402 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Pierce isDistinguished. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Dr. Pierce isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Pierce isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Colorectal CancerDr. Pierce isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Pierce isDistinguished. Learn about Familial Colorectal Cancer.
- Lung CancerDr. Pierce isDistinguished. Learn about Lung Cancer.
- Advanced
- Adult Immune ThrombocytopeniaDr. Pierce isAdvanced. Learn about Adult Immune Thrombocytopenia.
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Pierce isAdvanced. Learn about Anemia.
- AngiosarcomaDr. Pierce isAdvanced. Learn about Angiosarcoma.
- AstrocytomaDr. Pierce isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Experienced
- Acute Mountain SicknessDr. Pierce isExperienced. Learn about Acute Mountain Sickness.
- Adrenal CancerDr. Pierce isExperienced. Learn about Adrenal Cancer.
- Adult Soft Tissue SarcomaDr. Pierce isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Adult T-Cell LeukemiaDr. Pierce isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Pierce isExperienced. Learn about Agranulocytosis.
- Anal CancerDr. Pierce isExperienced. Learn about Anal Cancer.